Analysis of Herbal Constituents and In Vivo Pharmacokinetics of Gegen–Huangqi Decoction in Rat Plasma Using HPLC‐Q‐TOF‐MS/MS and HPLC‐QQQ‐MS/MS
Biomedical Chromatography · 2025-01 · 39 (1)
DOI: 10.1002/bmc.6046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 22.11.2024. Verfasst von Zhou Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Tandem Mass Spectrometry, Rats, Sprague-Dawley. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Science and Technology Major Project of China.
Abstract (Originalsprache)
The traditional Chinese medicine (TCM) formula, gegen–huangqi (GH) decoction, has been employed for over 200 years, notably for its therapeutic effects in treating conditions such as atherosclerosis and diabetes mellitus. Despite its long‐standing use, comprehensive studies on the chemical constituents of GH and their in vivo pharmacokinetics (PK) remain limited. This study aimed to profile the bioactive compounds present in GH decoction and to explore their PK characteristics using HPLC‐Q‐TOF‐MS/MS. Furthermore, a robust and validated analytical method was developed and applied to assess the PK of 11 plasma compounds using HPLC‐QQQ‐MS/MS. In total, 79 components were identified within the GH decoction. Pharmacokinetic analysis revealed distinct absorption and elimination profiles for compounds such as puerarin, daidzin, genistin, calycosin‐7‐O‐β‐D‐glucoside, and ononin, which exhibited profiles of quick absorption and excretion. Conversely, compounds such as daidzein, formononetin, genistein, astragaloside II, astragaloside IV, and calycosin showed more complex in vivo metabolic patterns, leading to multipeak concentration‐time curves. All compounds, except astragalosides II and IV, were found to undergo significant hepatic clearance. These findings provide valuable insights into the pharmacokinetic behavior of GH decoction, which lays the foundation for further quality control, pharmacological exploration, and potential clinical application of this traditional remedy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- School of Life Science and Bio-Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
- State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Nanchang, China.
ORCID-Profile: Chenggang Huang
Förderung
- National Science and Technology Major Project of China
Zitieren
APA
Xu, Z., Wang, L., Liu, H., Tian, X., Wang, Y., Xu, H., Chen, S., Chen, M., Hu, P., & Huang, C. (2025). Analysis of Herbal Constituents and In Vivo Pharmacokinetics of Gegen–Huangqi Decoction in Rat Plasma Using HPLC‐Q‐TOF‐MS/MS and HPLC‐QQQ‐MS/MS. Biomedical Chromatography, 39(1). https://doi.org/10.1002/bmc.6046
Vancouver
Xu Z, Wang L, Liu H, Tian X, Wang Y, Xu H, et al. Analysis of Herbal Constituents and In Vivo Pharmacokinetics of Gegen–Huangqi Decoction in Rat Plasma Using HPLC‐Q‐TOF‐MS/MS and HPLC‐QQQ‐MS/MS. Biomedical Chromatography. 2025;39(1). doi:10.1002/bmc.6046
BibTeX
@article{Xu2025,
author = {Xu, Zhou and Wang, Linwei and Liu, Huan and Tian, Xiaoting and Wang, Yangyang and Xu, Haibo and Chen, Shuoji and Chen, Mingcang and Hu, Pei and Huang, Chenggang},
title = {Analysis of Herbal Constituents and In Vivo Pharmacokinetics of Gegen–Huangqi Decoction in Rat Plasma Using HPLC‐Q‐TOF‐MS/MS and HPLC‐QQQ‐MS/MS},
journal = {Biomedical Chromatography},
year = {2025},
volume = {39},
number = {1},
doi = {10.1002/bmc.6046}
}
EUVIMED